Arkolith/Insider Trading/BHVN/Form 4

Gentile Kimberly

SVP, Clinical OperationsBiohaven Ltd. (BHVN) · full profile →Form 4 · filed Jan 7, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2026Tax withholding(F)2K$9.93$19K100K
Jan 5, 2026Option exercise(M)4K—$0102K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 5, 2026Option exercise(M)4K—$08K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001704186-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML